BSE Live
Feb 10, 16:01Prev. Close
75.23
Open Price
75.00
Bid Price (Qty.)
73.70 (1)
Offer Price (Qty.)
79.99 (1)
NSE Live
Feb 10, 15:52Prev. Close
74.57
Open Price
75.57
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Alpa Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 9.42 | 8.01 | 5.90 | 6.71 | 3.46 | |
| Diluted EPS (Rs.) | 9.42 | 8.01 | 5.90 | 6.71 | 3.46 | |
| Cash EPS (Rs.) | 10.40 | 8.90 | 6.63 | 7.50 | 4.04 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 86.41 | 76.98 | 68.69 | 62.56 | 55.85 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 86.41 | 76.98 | 68.69 | 62.56 | 55.85 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 53.45 | 51.68 | 44.18 | 53.36 | 46.36 | |
| PBDIT/Share (Rs.) | 13.45 | 10.94 | 8.31 | 10.21 | 5.76 | |
| PBIT/Share (Rs.) | 12.41 | 10.01 | 7.68 | 9.42 | 5.18 | |
| PBT/Share (Rs.) | 12.28 | 9.83 | 7.57 | 9.31 | 5.13 | |
| Net Profit/Share (Rs.) | 9.35 | 7.97 | 6.00 | 6.71 | 3.45 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 25.17 | 21.16 | 18.80 | 19.13 | 12.42 | |
| PBIT Margin (%) | 23.21 | 19.37 | 17.37 | 17.65 | 11.16 | |
| PBT Margin (%) | 22.97 | 19.01 | 17.13 | 17.44 | 11.06 | |
| Net Profit Margin (%) | 17.50 | 15.42 | 13.58 | 12.58 | 7.44 | |
| Return on Networth / Equity (%) | 10.82 | 10.35 | 8.73 | 10.73 | 6.18 | |
| Return on Capital Employed (%) | 14.01 | 12.81 | 10.94 | 14.54 | 9.24 | |
| Return on Assets (%) | 8.44 | 8.71 | 7.11 | 8.55 | 4.83 | |
| Total Debt/Equity (X) | 0.00 | 0.03 | 0.02 | 0.04 | 0.00 | |
| Asset Turnover Ratio (%) | 0.53 | 0.59 | 0.54 | 0.71 | 64.93 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.10 | 5.70 | 4.95 | 4.78 | 3.69 | |
| Quick Ratio (X) | 3.72 | 5.21 | 4.53 | 4.25 | 3.18 | |
| Inventory Turnover Ratio (X) | 7.18 | 8.27 | 3.73 | 3.96 | 5.89 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 217.43 | 179.49 | 106.96 | 149.84 | 65.84 | |
| EV/Net Operating Revenue (X) | 1.93 | 1.65 | 1.15 | 1.33 | 0.67 | |
| EV/EBITDA (X) | 7.68 | 7.80 | 6.12 | 6.98 | 5.43 | |
| MarketCap/Net Operating Revenue (X) | 1.95 | 1.61 | 1.22 | 1.30 | 0.78 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.21 | 1.08 | 0.78 | 1.11 | 0.65 | |
| Price/Net Operating Revenue | 1.95 | 1.61 | 1.22 | 1.30 | 0.78 | |
| Earnings Yield | 0.09 | 0.10 | 0.11 | 0.10 | 0.10 |
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y